Headlines

Obama: Won't favor ideology over science

CHICAGO, Dec. 20 (UPI) -- U.S. President-elect Barack Obama said Saturday he respects the scientific process and will work to restore the United States as a world science leader.

Science group posts interactive Web site

SAN FRANCISCO, Dec. 21 (UPI) -- The San Francisco-based Public Library of Science says its online journal will post research and allow interactive review before and after publication.

New open access journal announced

SAN FRANCISCO, Sept. 14 (UPI) -- A new open access journal, PLoS Neglected Tropical Diseases, is to begin accepting articles next year.

Mice study targets human lung cancer

NEW YORK, May 17 (UPI) -- U.S. scientists have created an animal model of lung adenocarcinoma that can be used to test the efficacy of targeted human lung cancer therapies.

PLoS to launch online medical journal

WASHINGTON, May 6 (UPI) -- Discoveries about health and disease will be made available to anyone with Internet access in a medical journal called PLoS Medicine, it was announced Thursday.

Congress, NIH clash on research issues

WASHINGTON, Oct. 3 (UPI) -- Top officials of the National Institutes of Health, called before a congressional committee to testify about reshaping the agency's research structure, found the discussion turning quickly to other issues, such as the ethics of human cloning and the value
KATRINA WOZNICKI, UPI Science News

Bush honors science, technology leaders

WASHINGTON, June 12 (UPI) -- President George W. Bush presented the 2001 National Medals of Science and Technology to 20 of the nation's premier scientists and innovators in an East Room ceremony Wednesday. "They've turned genius and perseverance into knowledge and technology that
SCOTT R. BURNELL, UPI Science News

Better mouse model for lung cancer

COLD SPRING HARBOR, N.Y., Dec. 14 (UPI) -- Independent research groups from Memorial Sloan-Kettering Cancer Center in New York City and the Massachusetts Institute of Technology in Cambridge, Mass., have

CFR Launches Terror Task Force

WASHINGTON, Oct. 19 (UPI) -- The Council on Foreign Relations has announced the formation of a new, independent task force that will focus on America's responses to terrorism.
Photos
Wiki

Harold Elliot Varmus (born December 18, 1939) is an American Nobel prize winning scientist. He was a co-recipient (along with J. Michael Bishop) of the 1989 Nobel Prize in Physiology or Medicine for discovery of the cellular origin of retroviral oncogenes.

He has been designated as one of co-chairs of the Council of Advisors on Science and Technology to serve in the Obama administration.

Varmus was born to Jewish parents of Eastern European descent in Oceanside, New York. In 1957, he enrolled at Amherst College, intending to follow in his father's footsteps as a medical doctor, but eventually graduating with a B.A. in English literature. He went on to earn a graduate degree in English at Harvard University in 1962 before changing his mind once again and applying to medical schools. That same year, he entered the College of Physicians and Surgeons at Columbia University and later worked at a missionary hospital in Bareilly, India and the Columbia-Presbyterian Hospital. Seeking to avoid the draft for the Vietnam War, Varmus joined the Public Health Service at the National Institutes of Health in 1968. Working under Ira Pastan, he researched regulation bacterial gene expression by cyclic AMP. In 1970, he began post-doctoral studies in Bishop's lab at University of California, San Francisco. There, he and Bishop performed the oncogene research that would win them the Nobel Prize. He became a faculty member at UCSF in 1972 and a professor in 1979.

This article is licensed under the GNU Free Documentation License.
It uses material from the Wikipedia article "Harold Varmus."
x
Feedback